NDC 71335-1249 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 2.5 mg/1; Amphetamine Aspartate Monohydrate 2.5 mg/1; Dextroamphetamine Sulfate 2.5 mg/1; Amphetamine Sulfate 2.5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC71335-1249

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA040439
Marketed since
June 14, 2002
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (5)

Package NDCDescriptionSince
71335-1249-160 TABLET in 1 BOTTLE (71335-1249-1)May 17, 2024
71335-1249-230 TABLET in 1 BOTTLE (71335-1249-2)Jun 17, 2019
71335-1249-390 TABLET in 1 BOTTLE (71335-1249-3)May 17, 2024
71335-1249-4120 TABLET in 1 BOTTLE (71335-1249-4)May 17, 2024
71335-1249-518 TABLET in 1 BOTTLE (71335-1249-5)May 17, 2024

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products